Diet and prostate cancer: mechanisms of action and implications for chemoprevention (Q34127237)

31 July 2017

1 reference

title

Diet and prostate cancer: mechanisms of action and implications for chemoprevention (English)

1 reference

31 July 2017

1 reference

2

Laurence H Klotz

1 reference

31 July 2017

author name string

Vasundara Venkateswaran

series ordinal

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

20 July 2010

1 reference

31 July 2017

published in

Nature Reviews Urology

1 reference

31 July 2017

volume

7

1 reference

31 July 2017

issue

8

1 reference

31 July 2017

page(s)

442-453

1 reference

31 July 2017

cites work

Cancer in Canada in 2008

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

N-Nitroso compounds in the diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Fat, meat, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

A combination of micronutrients is beneficial in reducing the incidence of prostate cancer and increasing survival in the Lady transgenic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

A prospective study of tomato products, lycopene, and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Cancer-preventive isothiocyanates: measurement of human exposure and mechanism of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Quality of life and satisfaction with outcome among prostate-cancer survivors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

International trends and patterns of prostate cancer incidence and mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

31 March 2020

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Cancer of the prostate: a nutritional disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Indications for transition zone biopsy in the detection of prostatic carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Polymorphisms in genes involved in androgen pathways as risk factors for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Risk factors for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Role of diet in prostate cancer development and progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

A prospective study of dietary fat and risk of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Dietary fat and prostate cancer: current status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

The role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Celecoxib for the prevention of colorectal adenomatous polyps

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Celecoxib for the prevention of sporadic colorectal adenomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

The influence of finasteride on the development of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Molecular targets for cancer chemoprevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Dietary intervention in the management of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Clinical trials in cancer prevention: current results and perspectives for the future

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Obesity and prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Risk factors for prostate cancer incidence and progression in the health professionals follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Premorbid diet in relation to survival from prostate cancer (Canada).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Prostate cancer prevention: past, present, and future

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Diet and serum sex hormones in healthy men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Decrease of serum total and free testosterone during a low-fat high-fibre diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Effects of a high-complex-carbohydrate, low-fat, low-cholesterol diet on levels of serum lipids and estradiol.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Effect of isocaloric low-fat diet on prostate cancer xenograft progression to androgen independence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Effect of isocaloric low fat diet on prostate cancer xenograft progression in a hormone deprivation model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Lipoxygenase-5 is overexpressed in prostate adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Multi-targeted therapy of cancer by omega-3 fatty acids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Growth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trial in men with prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Meat and meat-related compounds and risk of prostate cancer in a large prospective cohort study in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Heterocyclic amine content in beef cooked by different methods to varying degrees of doneness and gravy made from meat drippings.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Heterocyclic amine content of pork products cooked by different methods and to varying degrees of doneness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Iron and colorectal cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Red meat enhances the colonic formation of the DNA adduct O6-carboxymethyl guanine: implications for colorectal cancer risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Heme of consumed red meat can act as a catalyst of oxidative damage and could initiate colon, breast and prostate cancers, heart disease and other diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Development of a food frequency questionnaire module and databases for compounds in cooked and processed meats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Effect of white versus red meat on endogenous N-nitrosation in the human colon and further evidence of a dose response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Fat and meat intake and prostate cancer risk: the multiethnic cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

The roles of alpha-vitamin E and its analogues in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Effect of vitamin C and vitamin E on prostaglandin synthesis by fibroblasts and squamous carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Vitamin E and other antioxidants inhibit human prostate cancer cells through apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Synergistic effect of vitamin E and selenium in human prostate cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

gamma-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Dietary agents for chemoprevention of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Chemopreventive mechanisms of selenium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

A prospective study of plasma selenium levels and prostate cancer risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Selenium- or quercetin-induced retardation of DNA synthesis in primary prostate cells occurs in the presence of a concomitant reduction in androgen-receptor activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Tumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Use of antioxidants during chemotherapy and radiotherapy should be avoided.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: a good thing?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Delineating the mechanism by which selenium deactivates Akt in prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Alteration of cellular phenotype and responses to oxidative stress by manganese superoxide dismutase and a superoxide dismutase mimic in RWPE-2 human prostate adenocarcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's di

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Tomatoes, tomato products and lycopene in the prevention and treatment of prostate cancer: do we have the evidence from intervention studies?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Tomato products, lycopene, and prostate cancer: a review of the epidemiological literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Multitargeted therapy of cancer by lycopene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Drug Insight: lycopene in the prevention and treatment of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Effect of lycopene and beta-carotene on peroxynitrite-mediated cellular modifications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

The effect of lycopene on cell growth and oxidative DNA damage of Hep3B human hepatoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Are the health attributes of lycopene related to its antioxidant function?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Lycopene inhibits IGF-I signal transduction and growth in normal prostate epithelial cells by decreasing DHT-modulated IGF-I production in co-cultured reactive stromal cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Effect of lycopene on insulin-like growth factor-I, IGF binding protein-3 and IGF type-I receptor in prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Lycopene effects on rat normal prostate and prostate tumor tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Lycopene: modes of action to promote prostate health

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Effect of the consumption of tomato paste on plasma prostate-specific antigen levels in patients with benign prostate hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Lycopene for advanced hormone refractory prostate cancer: a prospective, open phase II pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

A prospective study of lycopene and tomato product intake and risk of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

The U.S. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Dietary intake of Cruciferous vegetables, Glutathione S-transferase (GST) polymorphisms and lung cancer risk in a Caucasian population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Prospective study of fruit and vegetable intake and risk of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Fruits and vegetables and prostate cancer: no association among 1104 cases in a prospective study of 130544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Prostate cancer incidence and intake of fruits, vegetables and related micronutrients: the multiethnic cohort study* (United States).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Modest induction of phase 2 enzyme activity in the F-344 rat prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Molecular basis for chemoprevention by sulforaphane: a comprehensive review.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Effect of isothiocyanates on nuclear accumulation of NF-kappaB, Nrf2, and thioredoxin in caco-2 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Pharmacokinetics and pharmacodynamics of broccoli sprouts on the suppression of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: implication of induction of Nrf2, HO-1 and apoptosis and the suppression of Akt-dependent ki

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Tea polyphenols: prevention of cancer and optimizing health

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Tea polyphenols for health promotion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Multitargeted therapy of cancer by green tea polyphenols

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

The protective effects of green tea in prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Genistein-selenium combination induces growth arrest in prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Phytochemicals: biochemistry and physiology. Introduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-)epigallocatechin-3-gallate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.102

Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells.

31 March 2020

1 reference

12 December 2020

A prospective study of cruciferous vegetables and prostate cancer.

1 reference

12 December 2020

Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis

1 reference

12 December 2020

Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines

1 reference

12 December 2020

Lycopene and beta-carotene ameliorate catechol estrogen-mediated DNA damage.

1 reference

12 December 2020

Interrelation of energy intake, body size, and physical activity with prostate cancer in a large prospective cohort study

1 reference

12 December 2020

Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells.

1 reference

12 December 2020

Selenium modulation of cell proliferation and cell cycle biomarkers in human prostate carcinoma cell lines

1 reference

12 December 2020

Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat

1 reference

12 December 2020

Vitamin E inhibits the high-fat diet promoted growth of established human prostate LNCaP tumors in nude mice

1 reference

12 December 2020

Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk

1 reference

12 December 2020

Red meat and colorectal cancer risk: the effect of dietary iron and haem on endogenous N-nitrosation

1 reference

12 December 2020

Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States

1 reference

12 December 2020

Glutathione transferase (GSTM1) null genotype, smoking, and prevalence of colorectal adenomas.

1 reference

12 December 2020

Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line.

1 reference

12 December 2020

Diet and urinary steroids in black and white North American men and black South African men

1 reference

12 December 2020

Cancer prevention science and practice

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2010.102

1 reference

Dimensions Publication ID

31 July 2017

1018874080

0 references

1 reference